CDKN2A and head and neck squamous cell carcinoma: Also, in HPV-negative HNSCC, the CDK6-inhibitory factors CDKN2A and let-7c are inactivated in 57% and 40% of all cases, while no or little inactivation occurs in HPV positive tumors.